Two Sigma Advisers’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-163,900
Closed -$18.5M 2258
2015
Q4
$18.5M Sell
163,900
-108,104
-40% -$11.9M 0.11% 218
2015
Q3
$32.2M Buy
272,004
+138,704
+104% +$18.1M 0.2% 127
2015
Q2
$10.3M Buy
133,300
+29,800
+29% +$1.95M 0.08% 289
2015
Q1
$5.99M Buy
103,500
+76,600
+285% +$3.25M 0.04% 438
2014
Q4
$868K Buy
+26,900
New +$808K 0.01% 1245

Other funds holding ANAC

Two Sigma Advisers's ANAC Position: Q1 2016 in Review

Two Sigma Advisers sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 163,900 shares — an estimated $18.5M sold.

Two Sigma Advisers first reported a position in ANAC in Q4 2014 and held it in 5 quarters. The position peaked at $32.2M in Q3 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

  • Two Sigma Advisers reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
  • Two Sigma Advisers sold 163,900 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $18.5M.
  • Two Sigma Advisers first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 5 quarters.
  • Two Sigma Advisers's ANACOR PHARMACEUTICALS INC COM position peaked at $32.2M in Q3 2015.
  • 199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Two Sigma Advisers's 13F filing for Q1 2016, filed 16 May 2016.